Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 915 of 5804
-
Could a common vaccine supercharge immunotherapy against melanoma?
Disease control Recruiting nowThe purpose of this study is to determine the safety and feasibility of administering the Tetanus Diptheria Vaccine (Td) or Polio Boost Immunization (IPOL) to patients with metastatic melanoma who are receiving immune checkpoint inhibitor (IO) therapy per standard of care. Subjec…
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Wearable patch aims to catch hidden heart rhythms that holter monitors miss
Diagnosis CompletedThis exploratory medical device study evaluated the arrhythmia diagnostic yield of MEMO Patch V2, a wearable patch-type electrocardiographic monitor, in adults with suspected arrhythmia who presented with symptoms such as palpitations or dizziness, or who had cryptogenic ischemic…
Phase: NA • Sponsor: HUINNO Co., Ltd • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New AI-Guided blood test could slash unnecessary antibiotic use
Diagnosis CompletedThis study is a proteomics-based diagnostic biomarker study conducted on the same patient cohort as the transcriptomic biomarker study (NCT065529754). Although both studies share the same clinical cohort and overarching diagnostic aim, they are registered separately because they …
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
21-Protein blood test aims to spot hidden heart failure in the ER
Diagnosis CompletedAcute heart failure is a common reason for emergency department visits and hospitalization, but the diagnosis can be challenging because of non-specific symptoms and signs. The current diagnostic approach to acute heart failure has modest accuracy, leading to delayed diagnosis an…
Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
New pill could cool menopause hot flashes without hormones
Symptom relief CompletedResearchers are looking for a better way to treat women who have hot flashes after they have been through the menopause. Hot flashes are caused by the hormonal changes that happen when a woman's body has been through the menopause. Menopause is when women stop having a menstrual …
Phase: PHASE3 • Sponsor: Bayer • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Experimental drug aims to tame severe COVID-19 inflammation
Disease control CompletedThe study is a randomized, double-blind, placebo-controlled, dose escalation, multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID-19 disease.
Phase: PHASE2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug hope for rare nerve cancer: tazemetostat under study
Disease control OngoingThis phase 2, open label, single arm study will investigate the use of tazemetostat in patients with recurrent/refractory and/or metastatic malignant peripheral nerve sheath tumors.
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a daily pill sharpen the minds of people with schizophrenia?
Symptom relief CompletedThis study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning. Examples include struggling to remember things, or to read a book or pay attention to a movie. Some people have difficulty calculating the…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New stent shows promise for clot removal in stroke patients
Disease control CompletedA prospective, multicenter, randomized controlled, non-inferiority study to investigate the effectiveness and safety of SINOMED SR for endovascular treatment of acute ischemic stroke
Phase: NA • Sponsor: Sinomed Neurovita Technology Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Weight loss pill combo may help teens keep pounds off
Disease control CompletedLong-term weight loss maintenance is seldom achieved by individuals with obesity owing to numerous biological adaptations occurring in the post-weight loss setting, including neuroendocrine-mediated changes in appetite/satiety and reduction of energy expenditure. Following weight…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug combo aims to fight melanoma when standard therapy fails
Disease control Recruiting nowThe goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New shot could help Immune-Compromised patients fight infections
Disease control OngoingProspective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcutaneous human immunoglobulin (Newnorm) in patients with primary immunodeficiency diseases
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a quicker chemo beat breast cancer better?
Disease control Recruiting nowStudies have shown that dose-dense chemotherapy reduces the risk of recurrence and death of breast cancer patients comparing with standard-schedule chemotherapy. But some research data indicate that HR+/HER2- breast cancer patients benefit from dose-dense chemotherapy while some …
Phase: PHASE2 • Sponsor: Shantou Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New radioactive drug targets Hard-to-Treat cancers
Disease control Recruiting nowFibroblast activation protein (FAP) is a cell surface protein that is highly expressed on the surface of cancer-associated fibroblasts (CAFs) present in the tumor microenvironment of most epithelial cancers, whereas limited expression of FAP is observed in normal tissues. In some…
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for women with Hard-to-Treat uterine cancer?
Disease control CompletedThis is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).
Phase: PHASE2 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a kidney cell injection slow Diabetes-Related kidney failure?
Disease control CompletedThe purpose of this study is to assess the safety, efficacy, and durability of up to two Renal Autologous Cell Therapy (REACT) / rilparencel injections delivered percutaneously into biopsied and non-biopsied contralateral kidneys on renal function progression in two different coh…
Phase: PHASE2 • Sponsor: Prokidney • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New artificial disc could replace fusion for neck pain
Disease control OngoingProspective, concurrently controlled, multi-center study to evaluate the safety and effectiveness of the Spinal Kinetics M6-C™ artificial cervical disc compared to anterior cervical discectomy and fusion (ACDF) for the treatment of contiguous two-level symptomatic cervical radicu…
Phase: NA • Sponsor: Orthofix Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a drug plus light therapy reverse vitiligo? new trial tests the combo
Disease control CompletedThe purpose of this phase 2 study is to evaluate the effect and the safety of the combination of Baricitinib in combination with phototherapy in adult participants with non-segmental progressive vitiligo.
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New brain aneurysm device shows promise in 142-Patient trial
Disease control CompletedThe purpose of this study is to assess the effectiveness and safety of the Flow Diverter (Tonbridge) by collecting data from subjects who receive endovascular treatment of intracranial aneurysms.
Phase: NA • Sponsor: Ton-Bridge Medical Tech. Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Major trial tests skipping radiation for Low-Risk breast cancer
Disease control Recruiting nowThis Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC